However, the greatest reduction in tumor volume (to 17.9 ± 2.2 % of control mice receiving IgG treatment) was seen in the group of mice that received triple therapy (HGF inhibition + c-MET inhibition + gemcitabine). The gene discussed is HGF; the disease is neoplasm.